{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:15:56Z","timestamp":1793272556867,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Differentiation of pituitary neuroendocrine tumor (PitNET) tissue from surrounding normal tissue during surgery is challenging. A number of fluorescent agents is available for visualization of tissue discrepancy, with the potential of improving total tumor resection. This review evaluates the availability, clinical and technical applicability of the various fluorescent agents within the field of pituitary surgery.\u00a0According to PRISMA guidelines, a systematic review was performed to identify reports describing results of <jats:italic>in vivo<\/jats:italic> application of fluorescent agents.\u00a0In this review, 15 publications were included. Sodium Fluorescein (FNa) was considered in two studies. The first study reported noticeable fluorescence in adenoma tissue, the second demonstrated the strongest fluorescence in non-functioning pituitary adenomas. 5-Aminolevulinic acid (5-ALA) was investigated in three studies. One study compared laser-based optical biopsy system (OBS) with photo-diagnostic filter (PD) and found that the OBS was able to detect all microadenomas, even when MRI was negative. The second study retrospectively analyzed twelve pituitary adenomas and found only one positive for fluorescence. The third investigated fifteen pituitary adenomas of which one displayed vague fluorescence. Indocyanine green (ICG) was researched in four studies with variable results. Second-Window ICG yielded no significant difference between functioning and non-functioning adenomas in one study, while a second study displayed 4 times higher fluorescence in tumor tissue than in normal tissue. In three studies, OTL38 showed potential in non-functioning pituitary adenomas.\u00a0At present, evidence for fluorescent agents to benefit total resection of PitNETs is lacking. OTL38 can potentially serve as a selective fluorescent agent in non-functioning pituitary adenomas in the near future.<\/jats:p>","DOI":"10.1007\/s11154-022-09718-9","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:03:42Z","timestamp":1648476222000},"page":"647-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-196X","authenticated-orcid":false,"given":"Rob A","family":"Vergeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-8524","authenticated-orcid":false,"given":"Robin E P","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6502-4818","authenticated-orcid":false,"given":"Theodora","family":"van Elk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-8209","authenticated-orcid":false,"given":"Mark R","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-4597","authenticated-orcid":false,"given":"Katalin","family":"Tamasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-5680","authenticated-orcid":false,"given":"J Marc C","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-5853","authenticated-orcid":false,"given":"Jos M A","family":"Kuijlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"9718_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11060-018-03062-2","volume":"141","author":"SW Chang","year":"2019","unstructured":"Chang SW, Donoho DA, Zada G. Use of optical fluorescence agents during surgery for pituitary adenomas: current state of the field. J Neurooncol. 2019;141:585\u201393.","journal-title":"J Neurooncol"},{"issue":"3","key":"9718_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-020-03420-z","volume":"151","author":"N Lakomkin","year":"2021","unstructured":"Lakomkin N, Van Gompel JJ, Post KD, Cho SS, Lee JYK, Hadjipanayis CG. Fluorescence guided surgery for pituitary adenomas. J Neurooncol. 2021;151(3):403\u201313.","journal-title":"J Neurooncol"},{"key":"9718_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ons\/opy034","volume":"16","author":"SS Cho","year":"2019","unstructured":"Cho SS, Zeh R, Pierce JT, Jeon J, Nasrallah M, Adappa ND, et al. Folate Receptor Near-Infrared Optical Imaging Provides Sensitive and Specific Intraoperative Visualization of Nonfunctional Pituitary Adenomas. Oper Neurosurg (Hagerstown). 2019;16:59\u201370.","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"9718_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11102-012-0440-6","volume":"16","author":"SS Shin","year":"2013","unstructured":"Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang Y-F, Zainah H, et al. Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary. 2013;16:435\u201344.","journal-title":"Pituitary"},{"key":"9718_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-12-0602","volume":"168","author":"C Sch\u00f6fl","year":"2013","unstructured":"Sch\u00f6fl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B, et al. Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol. 2013;168:39\u201347.","journal-title":"Eur J Endocrinol"},{"key":"9718_CR6","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, et al. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab. 2011;96:2732\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"9718_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jso.25105","volume":"118","author":"L van Manen","year":"2018","unstructured":"van Manen L, Handgraaf HJM, Diana M, Dijkstra J, Ishizawa T, Vahrmeijer AL, et al. A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery. J Surg Oncol. 2018;118:283.","journal-title":"J Surg Oncol"},{"key":"9718_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/jns.1948.5.4.0392","volume":"5","author":"GE Moore","year":"1948","unstructured":"Moore GE, Peyton WT, French LA, Walker WW. The Clinical Use of Fluorescein in Neurosurgery: The localization of brain tumors. J Neurosurg. 1948;5:392\u20138.","journal-title":"J Neurosurg"},{"key":"9718_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/atm.2016.10.70","volume":"4","author":"MJ Landau","year":"2016","unstructured":"Landau MJ, Gould DJ, Patel KM. Advances in fluorescent-image guided surgery. Annals of Translational Medicine. 2016;4:3\u20133.","journal-title":"Annals of Translational Medicine"},{"key":"9718_CR10","doi-asserted-by":"crossref","unstructured":"DSouza AV, Lin H, Henderson ER, Samkoe KS, Pogue BW. Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt 2016;21:80901.","DOI":"10.1117\/1.JBO.21.8.080901"},{"key":"9718_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3171\/jns.2003.99.3.0597","volume":"99","author":"J Shinoda","year":"2003","unstructured":"Shinoda J, Yano H, Yoshimura S-I, Okumura A, Kaku Y, Iwama T, et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium: Technical note. J Neurosurg. 2003;99:597\u2013603.","journal-title":"J Neurosurg"},{"key":"9718_CR12","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3171\/2019.1.JNS181512","volume":"132","author":"S Romano-Feinholz","year":"2019","unstructured":"Romano-Feinholz S, Alcocer-Barradas V, Ben\u00edtez-Gasca A, la Maza EM, Valencia-Ramos C, G\u00f3mez-Amador JL. Hybrid fluorescein-guided surgery for pituitary adenoma resection: a pilot study. J Neurosurg. 2019;132:1490\u20138.","journal-title":"J Neurosurg"},{"key":"9718_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/2152-7806.72247","volume":"1","author":"CE da Silva","year":"2010","unstructured":"da Silva CE, da Silva JLB, da Silva VD. Use of sodium fluorescein in skull base tumors. Surg Neurol Int. 2010;1:70.","journal-title":"Surg Neurol Int"},{"key":"9718_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11060-009-9820-9","volume":"92","author":"MS Eljamel","year":"2009","unstructured":"Eljamel MS, Leese G, Moseley H. Intraoperative optical identification of pituitary adenomas. J Neurooncol. 2009;92:417\u201321.","journal-title":"J Neurooncol"},{"key":"9718_CR15","doi-asserted-by":"crossref","unstructured":"Nemes A, Fortmann T, Poeschke S, Greve B, Prevedello D, Santacroce A, et al. 5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)? PLoS One 2016;11:e0161364.","DOI":"10.1371\/journal.pone.0161364"},{"key":"9718_CR16","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3171\/2018.7.JNS181642","volume":"131","author":"SS Cho","year":"2018","unstructured":"Cho SS, Jeon J, Buch L, Nag S, Nasrallah M, Low PS, et al. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas. J Neurosurg. 2018;131:1974\u201384.","journal-title":"J Neurosurg"},{"key":"9718_CR17","doi-asserted-by":"publisher","unstructured":"Marbacher S, Klinger E, Schwzer L, Fischer I, Nevzati E, Diepers M, et al. Use of Fluorescence to Guide Resection or Biopsy of Primary Brain Tumors and Brain Metastases. Journal of Neurological Surgery Part A: Central European Neurosurgery 2014;75. https:\/\/doi.org\/10.1055\/s-0034-1383791.","DOI":"10.1055\/s-0034-1383791"},{"key":"9718_CR18","doi-asserted-by":"crossref","unstructured":"Micko A, Rapoport BI, Youngerman BE, Fong RP, Kosty J, Brunswick A, et al. Limited utility of 5-ALA optical fluorescence in endoscopic endonasal skull base surgery: a multicenter retrospective study. J Neurosurg 2020;-1:1\u20137.","DOI":"10.1055\/s-0041-1725283"},{"key":"9718_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.gie.2007.01.009","volume":"66","author":"T Kimura","year":"2007","unstructured":"Kimura T, Muguruma N, Ito S, Okamura S, Imoto Y, Miyamoto H, et al. Infrared fluorescence endoscopy for the diagnosis of superficial gastric tumors. Gastrointest Endosc. 2007;66:37\u201343. https:\/\/doi.org\/10.1016\/j.gie.2007.01.009.","journal-title":"Gastrointest Endosc"},{"key":"9718_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/micr.10052","volume":"22","author":"C Holm","year":"2002","unstructured":"Holm C, Tegeler J, Mayr M, Becker A, Pfeiffer UJ, M\u00fchlbauer W. Monitoring free flaps using laser-induced fluorescence of indocyanine green: a preliminary experience. Microsurgery. 2002;22:278\u201387.","journal-title":"Microsurgery"},{"key":"9718_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00701-018-03778-0","volume":"161","author":"K Amano","year":"2019","unstructured":"Amano K, Aihara Y, Tsuzuki S, Okada Y, Kawamata T. Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors. Acta Neurochir. 2019;161:695\u2013706.","journal-title":"Acta Neurochir"},{"key":"9718_CR22","doi-asserted-by":"crossref","unstructured":"Kim EH, Cho JM, Chang JH, Kim SH, Lee KS. Application of intraoperative indocyanine green videoangiography to brain tumor surgery. Acta Neurochir 2011;153:1487\u201395; discussion 1494\u20135.","DOI":"10.1007\/s00701-011-1046-x"},{"key":"9718_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11102-014-0620-7","volume":"18","author":"N Sandow","year":"2015","unstructured":"Sandow N, Klene W, Elbelt U, Strasburger CJ, Vajkoczy P. Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach. Pituitary. 2015;18:613\u201320.","journal-title":"Pituitary"},{"key":"9718_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3171\/2012.1.jns11601","volume":"116","author":"ZN Litvack","year":"2012","unstructured":"Litvack ZN, Zada G, Laws ER. Indocyanine green fluorescence endoscopy for visual differentiation of pituitary tumor from surrounding structures. J Neurosurg. 2012;116:935\u201341. https:\/\/doi.org\/10.3171\/2012.1.jns11601.","journal-title":"J Neurosurg"},{"key":"9718_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1227\/neu.0000000000001328","volume":"12","author":"MJT Verstegen","year":"2016","unstructured":"Verstegen MJT, Tummers QR, Schutte PJ, Pereira AM, van Furth WR, van de Velde CJH, et al. Intraoperative Identification of a Normal Pituitary Gland and an Adenoma Using Near-Infrared Fluorescence Imaging and Low-Dose Indocyanine Green. Operative Neurosurgery. 2016;12:260\u20138. https:\/\/doi.org\/10.1227\/neu.0000000000001328.","journal-title":"Operative Neurosurgery"},{"key":"9718_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/ons\/opy213","volume":"17","author":"JW Jeon","year":"2019","unstructured":"Jeon JW, Cho SS, Nag S, Buch L, Pierce J, Su YS, et al. Near-Infrared Optical Contrast of Skull Base Tumors During Endoscopic Endonasal Surgery. Oper Neurosurg (Hagerstown). 2019;17:32\u201342.","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"9718_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/neuros\/nyy315","volume":"85","author":"DY Zhang","year":"2019","unstructured":"Zhang DY, Singhal S, Lee JYK. Optical Principles of Fluorescence-Guided Brain Tumor Surgery: A Practical Primer for the Neurosurgeon. Neurosurgery. 2019;85:312\u201324.","journal-title":"Neurosurgery"},{"key":"9718_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/2017.2.JNS163191","volume":"129","author":"JYK Lee","year":"2018","unstructured":"Lee JYK, Cho SS, Zeh R, Pierce JT, Martinez-Lage M, Adappa ND, et al. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging. J Neurosurg. 2018;129:390\u20134030.","journal-title":"J Neurosurg"},{"key":"9718_CR29","doi-asserted-by":"crossref","unstructured":"Almutairi RD, Muskens IS, Cote DJ, Dijkman MD, Kavouridis VK, Crocker E, Ghazawi K, Broekman MLD, Smith TR, Mekary RA, Zaidi HA. Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir (Wien). 2018;160(5):1005\u20131021.","DOI":"10.1007\/s00701-017-3438-z"},{"issue":"8","key":"9718_CR30","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00701-019-03955-9","volume":"161","author":"CP Soneru","year":"2019","unstructured":"Soneru CP, Riley CA, Hoffman K, Tabaee A, Schwartz TH. Intra-operative MRI vs endoscopy in achieving gross total resection of pituitary adenomas: a systematic review. Acta Neurochir (Wien). 2019;161(8):1683\u201398. https:\/\/doi.org\/10.1007\/s00701-019-03955-9.\u00a0Epub 28 May 2019 PMID: 31139934.","journal-title":"Acta Neurochir (Wien)"},{"key":"9718_CR31","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.wneu.2013.06.005","volume":"82","author":"D Jakimovski","year":"2014","unstructured":"Jakimovski D, Bonci G, Attia M, Shao H, Hofstetter C, Tsiouris AJ, et al. Incidence and significance of intraoperative cerebrospinal fluid leak in endoscopic pituitary surgery using intrathecal fluorescein. World Neurosurg. 2014;82:e513\u201323.","journal-title":"World Neurosurg"},{"key":"9718_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.nec.2019.05.002","volume":"30","author":"SS Cho","year":"2019","unstructured":"Cho SS, Lee JYK. Intraoperative Fluorescent Visualization of Pituitary Adenomas. Neurosurg Clin N Am. 2019;30:401\u201312.","journal-title":"Neurosurg Clin N Am"},{"key":"9718_CR33","doi-asserted-by":"publisher","unstructured":"Cho SS, Salinas R, Lee JYK. Indocyanine-Green for Fluorescence-Guided Surgery of Brain Tumors: Evidence, Techniques, and Practical Experience. Front Surg 2019;6. https:\/\/doi.org\/10.3389\/fsurg.2019.00011.","DOI":"10.3389\/fsurg.2019.00011"},{"key":"9718_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nec.2017.05.009","volume":"28","author":"W Stummer","year":"2017","unstructured":"Stummer W, Molina ES. Fluorescence Imaging\/Agents in Tumor Resection. Neurosurg Clin N Am. 2017;28:569\u201383. https:\/\/doi.org\/10.1016\/j.nec.2017.05.009.","journal-title":"Neurosurg Clin N Am"},{"key":"9718_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S2468-1253(16)30082-6","volume":"1","author":"NJ Harlaar","year":"2016","unstructured":"Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol. 2016;1:283\u201390.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9718_CR36","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1158\/1078-0432.CCR-16-0437","volume":"23","author":"LE Lamberts","year":"2017","unstructured":"Lamberts LE, Koch M, de Jong JS, Adams ALL, Glatz J, Kranendonk MEG, et al. Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study. Clin Cancer Res. 2017;23:2730\u201341.","journal-title":"Clin Cancer Res"},{"key":"9718_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/0008-5472.CAN-16-1773","volume":"77","author":"M Koch","year":"2017","unstructured":"Koch M, de Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams ALL, et al. Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer. Cancer Res. 2017;77:623\u201331.","journal-title":"Cancer Res"},{"key":"9718_CR38","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1158\/1078-0432.ccr-15-2937","volume":"22","author":"MCH Hekman","year":"2016","unstructured":"Hekman MCH, Boerman OC, de Weijert M, Bos DL, Oosterwijk E, Langenhuijsen HF, et al. Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study. Clin Cancer Res. 2016;22:4634\u201342. https:\/\/doi.org\/10.1158\/1078-0432.ccr-15-2937.","journal-title":"Clin Cancer Res"},{"key":"9718_CR39","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1158\/1078-0432.CCR-14-3284","volume":"21","author":"EL Rosenthal","year":"2015","unstructured":"Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, et al. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res. 2015;21:3658\u201366.","journal-title":"Clin Cancer Res"},{"key":"9718_CR40","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1158\/0008-5472.CAN-16-3217","volume":"77","author":"WS Tummers","year":"2017","unstructured":"Tummers WS, Warram JM, Tipirneni KE, Fengler J, Jacobs P, Shankar L, et al. Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection. Cancer Res. 2017;77:2197\u2013206.","journal-title":"Cancer Res"},{"key":"9718_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2967\/jnumed.115.158915","volume":"57","author":"EL Rosenthal","year":"2016","unstructured":"Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, et al. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. J Nucl Med. 2016;57:144\u201350.","journal-title":"J Nucl Med"},{"key":"9718_CR42","doi-asserted-by":"crossref","unstructured":"Scheuer W, van Dam GM, Dobosz M, Schwaiger M, Ntziachristos V. Drug-based optical agents: infiltrating clinics at lower risk. Sci Transl Med 2012;4:134ps11.","DOI":"10.1126\/scitranslmed.3003572"},{"key":"9718_CR43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11307-013-0652-9","volume":"15","author":"KE Day","year":"2013","unstructured":"Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol. 2013;15:722\u20139.","journal-title":"Mol Imaging Biol"},{"key":"9718_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2967\/jnumed.118.216556","volume":"60","author":"MD Linssen","year":"2019","unstructured":"Linssen MD, Ter Weele EJ, Allersma DP, Lub-de Hooge MN, van Dam GM, Jorritsma-Smit A, et al. Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW. J Nucl Med. 2019;60:418\u201323.","journal-title":"J Nucl Med"},{"key":"9718_CR45","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1002\/bjs.9713","volume":"102","author":"E de Boer","year":"2015","unstructured":"de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V, et al. Optical innovations in surgery. Br J Surg. 2015;102:e56-72.","journal-title":"Br J Surg"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-022-09718-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T06:28:15Z","timestamp":1653978495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-022-09718-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1007\/s11154-022-09718-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"3 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}